{"id":3905,"date":"2026-10-12T11:45:04","date_gmt":"2026-10-12T10:45:04","guid":{"rendered":"https:\/\/wpcalc.com\/tr\/tisbi\/has-bled-skoru-hesaplama\/"},"modified":"2026-10-12T11:45:04","modified_gmt":"2026-10-12T10:45:04","slug":"has-bled-skoru-hesaplama","status":"publish","type":"post","link":"https:\/\/wpcalc.com\/tr\/tisbi\/has-bled-skoru-hesaplama\/","title":{"rendered":"HAS-BLED Skoru Hesaplama"},"content":{"rendered":"<section class=\"not-prose calculator-box\" aria-labelledby=\"calculator-title\"><div class=\"flex items-baseline sm:items-center justify-between gap-2 sm:gap-3\"><div class=\"flex flex-col sm:flex-row sm:items-center gap-2\"><span class=\"icon icon-calculator text-primary-700! text-base! dark:text-primary-300!\" aria-hidden=\"true\"><\/span><h2 id=\"calculator-title\" class=\"text-lg font-display font-bold\">Antikoag\u00fclasyon \u00d6ncesi Kanama Riskinin De\u011ferlendirilmesi<\/h2><\/div><div class=\"calcdash-favorite group\">\n  <button type=\"button\" class=\"favorite\" id=\"favorite\" data-favorite-id=\"3905\" data-favorite-title=\"HAS-BLED Skoru\" data-favorite-url=\"https:\/\/wpcalc.com\/tr\/tisbi\/has-bled-skoru-hesaplama\/\" data-favorite-excerpt=\"Atriyal fibrilasyonlu hastada antikoag\u00fclasyona ba\u015flamadan \u00f6nce bir y\u0131ll\u0131k maj\u00f6r kanama riskini tahmin edin. Uygun risk fakt\u00f6rlerini i\u015faretleyin; HAS-BLED skoru, kanama oran\u0131 ve yorum an\u0131nda ekranda g\u00f6r\u00fcn\u00fcr.\" aria-label=\"Favorilere ekle\" data-favorite-icon=\"icon icon-heartbeat\">\n    <span class=\"icon icon-shape-star-empty\" aria-hidden=\"true\"><\/span>\n  <\/button>\n  <div class=\"calcdash-favorite__tip\" aria-hidden=\"true\">\n   <span class=\"favorite-tooltip\" id=\"favorite-tooltip\"><\/span>\n  <\/div>\n  <span class=\"sr-only\" role=\"status\" id=\"favorite-status\"><\/span>\n<\/div><\/div><form action=\"https:\/\/wpcalc.com\/tr\/tisbi\/has-bled-skoru-hesaplama\/\" method=\"POST\" class=\"calculator\" id=\"calculator-3905\" data-post=\"3905\"><fieldset class=\"fieldset-input is-1\"><legend class=\"sr-only\">Giri\u015f alanlar\u0131<\/legend><div class=\"field is-checkbox\" id=\"input-1\"><input type=\"checkbox\" id=\"field-1\" value=\"1\" checked=\"checked\"\/><label for=\"field-1\">Hipertansiyon (kontrols\u00fcz, sistolik &gt; 160 mmHg)<\/label><\/div><div class=\"field is-checkbox\" id=\"input-2\"><input type=\"checkbox\" id=\"field-2\" value=\"1\"\/><label for=\"field-2\">Anormal b\u00f6brek fonksiyonu<\/label><\/div><div class=\"field is-checkbox\" id=\"input-3\"><input type=\"checkbox\" id=\"field-3\" value=\"1\"\/><label for=\"field-3\">Anormal karaci\u011fer fonksiyonu<\/label><\/div><div class=\"field is-checkbox\" id=\"input-4\"><input type=\"checkbox\" id=\"field-4\" value=\"1\"\/><label for=\"field-4\">\u0130nme \u00f6yk\u00fcs\u00fc<\/label><\/div><div class=\"field is-checkbox\" id=\"input-5\"><input type=\"checkbox\" id=\"field-5\" value=\"1\"\/><label for=\"field-5\">Kanama \u00f6yk\u00fcs\u00fc veya yatk\u0131nl\u0131k<\/label><\/div><div class=\"field is-checkbox\" id=\"input-6\"><input type=\"checkbox\" id=\"field-6\" value=\"1\"\/><label for=\"field-6\">Labil INR<\/label><\/div><div class=\"field is-checkbox\" id=\"input-7\"><input type=\"checkbox\" id=\"field-7\" value=\"1\" checked=\"checked\"\/><label for=\"field-7\">Ya\u015fl\u0131l\u0131k (65 ya\u015f \u00fcst\u00fc)<\/label><\/div><div class=\"field is-checkbox\" id=\"input-8\"><input type=\"checkbox\" id=\"field-8\" value=\"1\"\/><label for=\"field-8\">Kanamaya yatk\u0131nl\u0131k olu\u015fturan ila\u00e7lar<\/label><\/div><div class=\"field is-checkbox\" id=\"input-9\"><input type=\"checkbox\" id=\"field-9\" value=\"1\"\/><label for=\"field-9\">Alkol kullan\u0131m\u0131 (haftada \u2265 8 i\u00e7ki)<\/label><\/div><\/fieldset><div class=\"buttons\"><button type=\"submit\" data-text=\"Yeniden hesapla\" id=\"calculate-button\" data-post=\"3905\">Hesapla<\/button><button type=\"reset\">S\u0131f\u0131rla<\/button><\/div><div class=\"field is-checkbox hidden!\" id=\"field-auto-calc\"><input type=\"checkbox\" id=\"auto-calc\"><label for=\"auto-calc\">Otomatik hesapla<\/label><small>Etkinle\u015ftirilirse, herhangi bir de\u011feri de\u011fi\u015ftirdi\u011finizde sonu\u00e7 otomatik olarak g\u00fcncellenir.<\/small><\/div><div class=\"fieldset-result is-hidden\" aria-labelledby=\"result-title\" aria-live=\"polite\" role=\"region\"> <h3 class=\"result-title bg-gradient-to-r from-primary-50 to-gray-50 dark:from-primary-900 dark:to-gray-800\" id=\"result-title\"><span class=\"icon icon-s-pulse\" aria-hidden=\"true\"><\/span> HAS-BLED Sonucu<\/h3><div class=\"result-box\"><div class=\"field-result\" id=\"output-1\"><span class=\"field-title\"><span>HAS-BLED skoru (en fazla 9):<\/span><span class=\"result-term\">skor<\/span><\/span><span class=\"field-value\" id=\"result-1\" data-unit=\"puan\"><\/span><button type=\"button\" class=\"copy-result\" data-tooltip=\"Sonucu kopyala\" aria-label=\"Sonucu kopyala\"><span class=\"copy-icon icon icon-document-copy\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"field-result is-column\" id=\"output-2\"><span class=\"field-title\"><span>Maj\u00f6r kanama oran\u0131:<\/span><\/span><span class=\"field-value\" id=\"result-2\"><\/span><button type=\"button\" class=\"copy-result\" data-tooltip=\"Sonucu kopyala\" aria-label=\"Sonucu kopyala\"><span class=\"copy-icon icon icon-document-copy\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"field-result is-column\" id=\"output-3\"><span class=\"field-title\"><span>Kanama riski yorumu:<\/span><\/span><span class=\"field-value\" id=\"result-3\"><\/span><button type=\"button\" class=\"copy-result\" data-tooltip=\"Sonucu kopyala\" aria-label=\"Sonucu kopyala\"><span class=\"copy-icon icon icon-document-copy\" aria-hidden=\"true\"><\/span><\/button><\/div><\/div><div class=\"result-actions\"><button type=\"button\" class=\"copy-link\"><svg viewBox=\"0 0 20 20\" fill=\"currentColor\" aria-hidden=\"true\"><path d=\"M12.232 4.232a2.5 2.5 0 0 1 3.536 3.536l-1.225 1.224a.75.75 0 0 0 1.061 1.06l1.224-1.224a4 4 0 0 0-5.656-5.656l-3 3a4 4 0 0 0 .225 5.865.75.75 0 0 0 .977-1.138 2.5 2.5 0 0 1-.142-3.667l3-3Z\"\/><path d=\"M11.603 7.963a.75.75 0 0 0-.977 1.138 2.5 2.5 0 0 1 .142 3.667l-3 3a2.5 2.5 0 0 1-3.536-3.536l1.225-1.224a.75.75 0 0 0-1.061-1.06l-1.224 1.224a4 4 0 1 0 5.656 5.656l3-3a4 4 0 0 0-.225-5.865Z\"\/><\/svg><span class=\"copy-link__text\">Bu hesaplaman\u0131n ba\u011flant\u0131s\u0131n\u0131 kopyala<\/span><\/button><span class=\"sr-only\" role=\"status\" id=\"copy-link-status\"><\/span><\/div><\/div><a href=\"#respond\" class=\"hidden transition-opacity duration-300 opacity-0 w-50 text-sm justify-center items-center gap-2 px-4 py-2 rounded bg-gray-200 text-gray-700 hover:bg-gray-300\" id=\"leave-comment\"><span class=\"icon icon-comments\" aria-hidden=\"true\"><\/span>Yorum b\u0131rak<\/a><\/form><\/section><section id=\"calc-reactions\" class=\"not-prose hidden my-12 bg-gradient-to-r from-primary-50 to-gray-50 border border-indigo-100 rounded-xl px-6 py-4 shadow-sm\" data-post=\"3905\" aria-live=\"polite\" aria-labelledby=\"calc-reactions-title\"><p id=\"calc-reactions-title\" class=\"text-sm text-gray-500 text-center mb-2\">Bu sonu\u00e7 hakk\u0131nda ne d\u00fc\u015f\u00fcn\u00fcyorsunuz?<\/p><div role=\"group\" aria-labelledby=\"calc-reactions-title\" class=\"grid grid-cols-3 sm:flex sm:flex-row sm:justify-around gap-4 sm:items-center sm:flex-wrap\"><button type=\"button\" aria-pressed=\"false\" class=\"reaction-btn flex flex-col items-center gap-1 text-sm text-gray-700 hover:text-primary-600 cursor-pointer transition-transform hover:scale-105\" data-reaction=\"like\"><span class=\"reaction-count\" data-reaction-count=\"like\">0<\/span><span class=\"reaction text-3xl\" aria-hidden=\"true\">\ud83d\ude00 <\/span><span class=\"reaction-description font-medium\">Be\u011fendim <\/span><\/button><button type=\"button\" aria-pressed=\"false\" class=\"reaction-btn flex flex-col items-center gap-1 text-sm text-gray-700 hover:text-primary-600 cursor-pointer transition-transform hover:scale-105\" data-reaction=\"helpful\"><span class=\"reaction-count\" data-reaction-count=\"helpful\">0<\/span><span class=\"reaction text-3xl\" aria-hidden=\"true\">\ud83d\udca1 <\/span><span class=\"reaction-description font-medium\">Faydal\u0131 <\/span><\/button><button type=\"button\" aria-pressed=\"false\" class=\"reaction-btn flex flex-col items-center gap-1 text-sm text-gray-700 hover:text-primary-600 cursor-pointer transition-transform hover:scale-105\" data-reaction=\"confused\"><span class=\"reaction-count\" data-reaction-count=\"confused\">0<\/span><span class=\"reaction text-3xl\" aria-hidden=\"true\">\ud83d\ude15 <\/span><span class=\"reaction-description font-medium\">Kafam kar\u0131\u015ft\u0131 <\/span><\/button><button type=\"button\" aria-pressed=\"false\" class=\"reaction-btn flex flex-col items-center gap-1 text-sm text-gray-700 hover:text-primary-600 cursor-pointer transition-transform hover:scale-105\" data-reaction=\"disappointed\"><span class=\"reaction-count\" data-reaction-count=\"disappointed\">0<\/span><span class=\"reaction text-3xl\" aria-hidden=\"true\">\ud83d\ude1e <\/span><span class=\"reaction-description font-medium\">Hayal k\u0131r\u0131kl\u0131\u011f\u0131 <\/span><\/button><button type=\"button\" aria-pressed=\"false\" class=\"reaction-btn flex flex-col items-center gap-1 text-sm text-gray-700 hover:text-primary-600 cursor-pointer transition-transform hover:scale-105\" data-reaction=\"inaccurate\"><span class=\"reaction-count\" data-reaction-count=\"inaccurate\">0<\/span><span class=\"reaction text-3xl\" aria-hidden=\"true\">\u274c <\/span><span class=\"reaction-description font-medium\">Hatal\u0131 <\/span><\/button><\/div><div id=\"reaction-message\" class=\"hidden mt-8 rounded-md border border-primary-100 bg-white\/50 backdrop-blur-sm px-4 py-2 text-sm text-center shadow-sm\"><\/div><\/section><div class=\"calcdash-ad not-prose calcdash-ad--calc_result calcdash-ad--in-article\"><ins class=\"adsbygoogle\" style=\"display:block\" data-ad-client=\"ca-pub-1721569815777345\" data-ad-slot=\"6317458308\" data-ad-layout=\"in-article\" data-ad-format=\"fluid\"><\/ins><script>(adsbygoogle = window.adsbygoogle || []).push({});<\/script><\/div>\n<style id=\"wpcoderpro-inline-1\">.formula-box {\r\n\tborder-bottom: none !important;\r\n}<\/style><section class=\"formula-box\" aria-labelledby=\"formula-title\">\r\n\t<div id=\"formula-title\" class=\"not-prose font-display mb-4\"><span class=\"icon icon-formula\" aria-hidden=\"true\"><\/span><h2>HAS-BLED Skoru Form\u00fcl\u00fc<\/h2><\/div>\r\n\t<figure class=\"not-prose formula\">\r\n\t\t<figcaption class=\"formula-title\">Form\u00fcl<\/figcaption>\r\n\t\t<div class=\"text-base text-gray-800\" id=\"formula\">\n\\[ \\text{HAS-BLED} = H + A_1 + A_2 + S + B + L + E + D_1 + D_2 \\]<\/div>\r\n\t<\/figure>\r\n\t<\/p>\n<p><strong>Burada:<\/strong><\/p>\n<ul>\n<li>\\(H\\) \u2014 kontrols\u00fcz hipertansiyon, sistolik kan bas\u0131nc\u0131 &gt; 160 mmHg (1 puan)<\/li>\n<li>\\(A_1\\) \u2014 anormal b\u00f6brek fonksiyonu: diyaliz, transplantasyon veya kreatinin &gt; 200 \u00b5mol\/L \/ 2,26 mg\/dL (1 puan)<\/li>\n<li>\\(A_2\\) \u2014 anormal karaci\u011fer fonksiyonu: kronik karaci\u011fer hastal\u0131\u011f\u0131, bilirubin &gt; 2\u00d7 normal veya AST\/ALT\/ALP &gt; 3\u00d7 normal (1 puan)<\/li>\n<li>\\(S\\) \u2014 ge\u00e7irilmi\u015f inme, ge\u00e7ici iskemik atak (TIA) veya sistemik emboli (1 puan)<\/li>\n<li>\\(B\\) \u2014 kanama \u00f6yk\u00fcs\u00fc veya yatk\u0131nl\u0131k; anemi veya k\u0131r\u0131lgan v\u00fccut yap\u0131s\u0131 dahil (1 puan)<\/li>\n<li>\\(L\\) \u2014 labil INR, yani varfarin kullan\u0131m\u0131nda terap\u00f6tik aral\u0131kta ge\u00e7irilen s\u00fcre &lt; %60 (1 puan)<\/li>\n<li>\\(E\\) \u2014 ileri ya\u015f, 65 ya\u015f \u00fcst\u00fc (1 puan)<\/li>\n<li>\\(D_1\\) \u2014 kanamaya yatk\u0131nl\u0131k yapan ila\u00e7lar: antiplatelet ila\u00e7lar veya NSA\u0130\u0130 (1 puan)<\/li>\n<li>\\(D_2\\) \u2014 haftada 8 veya daha fazla alkoll\u00fc i\u00e7ki t\u00fcketimi (1 puan)<\/li>\n<\/ul>\n<p>Mevcut her risk fakt\u00f6r\u00fc 1 puan ekler ve toplam en fazla 9 puana ula\u015fabilir. Toplam skor, antikoag\u00fclan tedavi d\u00fc\u015f\u00fcn\u00fclen atriyal fibrilasyonlu bir hastadaki maj\u00f6r kanama riskini tahmin eder.<\/p>\n<p>\r\n<\/section>\n<style id=\"wpcoderpro-inline-2\">.calculation-box {\r\n\tborder-bottom: none !important;\r\n}<\/style><section id=\"calculation\" class=\"calculation-box\" aria-labelledby=\"calculation-title\">\r\n\t<div id=\"calculation-title\" class=\"not-prose font-display\"><span class=\"icon icon-unordered-list\" aria-hidden=\"true\"><\/span><h2>HAS-BLED Skoru \u2013 \u00d6rnek Hesaplama<\/h2><\/div>\r\n\r\n<p>{formula}<\/p>\n<p><strong>\u00d6rnek:<\/strong> 72 ya\u015f\u0131ndaki atriyal fibrilasyonlu hastada kontrols\u00fcz hipertansiyon (sistolik bas\u0131n\u00e7 160 mmHg \u00fczerinde) mevcuttur; ancak b\u00f6brek ya da karaci\u011fer hastal\u0131\u011f\u0131 yok, inme veya kanama \u00f6yk\u00fcs\u00fc yok, varfarin kullanm\u0131yor, antiplatelet ila\u00e7 veya NSA\u0130\u0130 alm\u0131yor ve haftada 8 i\u00e7kiden az alkol t\u00fcketiyor.<\/p>\n<p>\\[ E = 1,\\quad H = 1,\\quad A_1 = A_2 = S = B = L = D_1 = D_2 = 0 \\]<\/p>\n<p>\\[ \\text{HAS-BLED} = 1 + 0 + 0 + 0 + 0 + 0 + 1 + 0 + 0 = 2 \\]<\/p>\n<p><strong>Sonu\u00e7:<\/strong> HAS-BLED skoru = 2 puan; bu, 100 hasta-y\u0131l\u0131 ba\u015f\u0131na yakla\u015f\u0131k 1,88 maj\u00f6r kanamaya kar\u015f\u0131l\u0131k gelir \u2014 d\u00fc\u015f\u00fck ile orta aras\u0131 kanama riski. Antikoag\u00fclasyon genellikle yine de gerekir, ancak kan bas\u0131nc\u0131 kontrol\u00fcn\u00fcn iyile\u015ftirilmesi ve hastan\u0131n d\u00fczenli olarak izlenmesi gerekir.<\/p>\n<p>\n\r\n<\/section>\n<h2>HAS-BLED Hesaplama Arac\u0131 Nas\u0131l Kullan\u0131l\u0131r?<\/h2>\n<ol>\n<li>Puanlamaya ba\u015flamadan \u00f6nce hastan\u0131n \u00f6yk\u00fcs\u00fcn\u00fc, laboratuvar sonu\u00e7lar\u0131n\u0131 ve ila\u00e7 listesini g\u00f6zden ge\u00e7irin \u2014 maddelerin \u00e7o\u011fu objektif verilere dayan\u0131r.<\/li>\n<li><strong>Hipertansiyon (kontrols\u00fcz, sistolik &gt; 160 mmHg)<\/strong> kutusunu yaln\u0131zca kan bas\u0131nc\u0131 ger\u00e7ekten kontrols\u00fczse i\u015faretleyin; iyi tedavi edilen hipertansiyon puan kazand\u0131rmaz.<\/li>\n<li><strong>Anormal b\u00f6brek fonksiyonu<\/strong> ve <strong>anormal karaci\u011fer fonksiyonu<\/strong> kutular\u0131n\u0131, her maddenin alt\u0131nda belirtilen \u00f6l\u00e7\u00fctlere g\u00f6re i\u015faretleyin.<\/li>\n<li>\u00d6yk\u00fc maddelerini i\u015faretleyin: <strong>\u0130nme \u00f6yk\u00fcs\u00fc<\/strong>, <strong>Kanama \u00f6yk\u00fcs\u00fc veya yatk\u0131nl\u0131k<\/strong> ve <strong>Labil INR<\/strong> (yaln\u0131zca varfarin kullanan hastalar i\u00e7in ge\u00e7erlidir).<\/li>\n<li>Hasta 65 ya\u015f\u0131ndan b\u00fcy\u00fckse <strong>\u0130leri ya\u015f (65 ya\u015f \u00fcst\u00fc)<\/strong> kutusunu i\u015faretleyin.<\/li>\n<li>Antiplatelet ila\u00e7lar (aspirin, klopidogrel) veya NSA\u0130\u0130 i\u00e7in <strong>Kanamaya yatk\u0131nl\u0131k yapan ila\u00e7lar<\/strong>, haftada 8 veya daha fazla i\u00e7ki t\u00fcketimi i\u00e7in <strong>Alkol kullan\u0131m\u0131<\/strong> kutusunu i\u015faretleyin.<\/li>\n<li>Altta g\u00f6r\u00fcnen <strong>HAS-BLED skorunu (en fazla 9)<\/strong>, tahmini <strong>maj\u00f6r kanama oran\u0131n\u0131<\/strong> ve <strong>kanama riski yorumunu<\/strong> okuyun.<\/li>\n<\/ol>\n<h2>HAS-BLED Skoru Nedir?<\/h2>\n<p>HAS-BLED skoru, antikoag\u00fclasyon aday\u0131 olan atriyal fibrilasyonlu hastalarda maj\u00f6r kanama riskini tahmin etmek i\u00e7in kullan\u0131lan, do\u011frulu\u011fu kan\u0131tlanm\u0131\u015f bir klinik ara\u00e7t\u0131r. 2010'da Pisters ve \u00e7al\u0131\u015fma arkada\u015flar\u0131 taraf\u0131ndan tan\u0131t\u0131lm\u0131\u015f ve o tarihten beri <a href=\"https:\/\/wpcalc.com\/tr\/tisbi\/cha2ds2-vasc-skoru\/\">CHA\u2082DS\u2082-VASc skoru<\/a> ile yap\u0131lan inme riski de\u011ferlendirmesinin tamamlay\u0131c\u0131s\u0131 olarak Avrupa Kardiyoloji Derne\u011fi'nin k\u0131lavuzlar\u0131 dahil ba\u015fl\u0131ca k\u0131lavuzlara girmi\u015ftir.<\/p>\n<p>Ad\u0131, sayd\u0131\u011f\u0131 risk fakt\u00f6rlerinin ba\u015f harflerinden olu\u015fan bir k\u0131saltmad\u0131r: Hipertansiyon (H), anormal b\u00f6brek veya karaci\u011fer fonksiyonu (A), inme (S), kanama \u00f6yk\u00fcs\u00fc (B), labil INR (L), ileri ya\u015f (E) ve ila\u00e7lar ya da alkol (D). Her fakt\u00f6r 1 puand\u0131r ve toplam 0 ile 9 aras\u0131nda de\u011fi\u015fir. Orijinal do\u011frulama kohortunda maj\u00f6r kanama oran\u0131, skor 0'da 100 hasta-y\u0131l\u0131 ba\u015f\u0131na yakla\u015f\u0131k 1,1 olaydan skor 4'te yakla\u015f\u0131k 8,7'ye y\u00fckselmi\u015f; daha y\u00fcksek skorlarda daha da artm\u0131\u015ft\u0131r.<\/p>\n<p>\u0130ki skor farkl\u0131 sorulara yan\u0131t verir ve birlikte kullan\u0131lmal\u0131d\u0131r. CHA\u2082DS\u2082-VASc, hastan\u0131n tedavisizken inme ge\u00e7irme olas\u0131l\u0131\u011f\u0131n\u0131, dolay\u0131s\u0131yla antikoag\u00fclasyondan ne kadar kazan\u00e7 sa\u011flayaca\u011f\u0131n\u0131 tahmin eder. HAS-BLED ise tedavi s\u0131ras\u0131nda maj\u00f6r kanama ge\u00e7irme olas\u0131l\u0131\u011f\u0131n\u0131 tahmin eder. Y\u00fcksek bir HAS-BLED skoru, daha yak\u0131ndan izlenmesi gereken hastalar\u0131 i\u015faret eder \u2014 bir uyar\u0131 i\u015faretidir, kontrendikasyon de\u011fildir.<\/p>\n<h2>Sonucun Yorumlanmas\u0131<\/h2>\n<p>0 veya 1 puan d\u00fc\u015f\u00fck kanama riski anlam\u0131na gelir: inme \u00f6nlemek amac\u0131yla yap\u0131lacak antikoag\u00fclasyon genellikle uygundur, \u00e7\u00fcnk\u00fc yarar riskten a\u00e7\u0131k\u00e7a fazlad\u0131r. 2 puan, d\u00fc\u015f\u00fck ile orta aras\u0131 bir riski g\u00f6sterir; tedavi genellikle yine de gerekir, ancak de\u011fi\u015ftirilebilir risk fakt\u00f6rlerinin ele al\u0131nmas\u0131 gerekir. 3 ve \u00fczeri puan y\u00fcksek kanama riski kabul edilir; k\u0131lavuzlar dikkatli olmay\u0131 ve d\u00fczenli de\u011ferlendirme yap\u0131lmas\u0131n\u0131 \u00f6nerir \u2014 \u00f6rne\u011fin tedavi ba\u015flat\u0131ld\u0131ktan veya de\u011fi\u015ftirildikten sonra 4 haftada bir kontrol.<\/p>\n<p>En \u00f6nemlisi, y\u00fcksek bir HAS-BLED skoru antikoag\u00fclasyonun otomatik olarak verilmesini engellemek i\u00e7in bir neden de\u011fildir. Skorun sayd\u0131\u011f\u0131 fakt\u00f6rlerin \u00e7o\u011fu d\u00fczeltilebilir: kan bas\u0131nc\u0131 kontrol alt\u0131na al\u0131nabilir, alkol t\u00fcketimi azalt\u0131labilir, NSA\u0130\u0130 ve gereksiz antiplatelet ila\u00e7lar b\u0131rak\u0131labilir ve labil INR, uygun durumlarda varfarinden DOAK'a ge\u00e7ilerek iyile\u015ftirilebilir. Skor, kimin m\u00fcdahaleye ihtiyac\u0131 oldu\u011funu belirler; kimin tedavisiz kalmas\u0131 gerekti\u011fini de\u011fil.<\/p>\n<h2>S\u0131n\u0131rl\u0131l\u0131klar ve Pratik \u00d6neriler<\/h2>\n<ul>\n<li><strong>Bir uyar\u0131 bayra\u011f\u0131d\u0131r, dur i\u015fareti de\u011fil.<\/strong> HAS-BLED'in en s\u0131k yanl\u0131\u015f kullan\u0131m\u0131, y\u00fcksek skor nedeniyle antikoag\u00fclasyonu geri \u00e7ekmektir; k\u0131lavuzlar bunun yap\u0131lmamas\u0131n\u0131 a\u00e7\u0131k\u00e7a vurgular.<\/li>\n<li><strong>Tedavi s\u0131ras\u0131ndaki kanamay\u0131 \u00f6ng\u00f6r\u00fcr.<\/strong> Skor antikoag\u00fcle edilmi\u015f hastalardan t\u00fcretildi\u011fi i\u00e7in, tedaviyi ger\u00e7ekten alacak ki\u015filer aras\u0131ndaki riski ay\u0131rt etmede en g\u00fc\u00e7l\u00fcd\u00fcr.<\/li>\n<li><strong>B\u00f6brek ve karaci\u011fer \u00f6l\u00e7\u00fctleri \u00f6zeldir.<\/strong> Hafif anormallikler i\u00e7in bu kutular\u0131 i\u015faretlemeyin. B\u00f6brek fonksiyon bozuklu\u011fu; diyaliz, transplantasyon veya 200 \u00b5mol\/L (2,26 mg\/dL) \u00fczerinde kreatinin demektir; b\u00f6brek fonksiyonunun daha geni\u015f bir g\u00f6r\u00fcn\u00fcm\u00fc i\u00e7in <a href=\"https:\/\/wpcalc.com\/tr\/tisbi\/egfr-hesaplama-ckd-epi-2021\/\">eGFR hesaplama arac\u0131na (CKD-EPI 2021)<\/a> bak\u0131n. Karaci\u011fer fonksiyon bozuklu\u011fu i\u00e7in kronik karaci\u011fer hastal\u0131\u011f\u0131 veya belirtilen laboratuvar e\u015fikleri gerekir; <a href=\"https:\/\/wpcalc.com\/en\/medical\/meld-na-score-calculator\/\">MELD-Na skoru<\/a> karaci\u011fer hastal\u0131\u011f\u0131n\u0131n \u015fiddeti hakk\u0131nda daha kapsaml\u0131 bir de\u011ferlendirme sunar.<\/li>\n<li><strong>Labil INR yaln\u0131zca varfarin i\u00e7in ge\u00e7erlidir.<\/strong> Do\u011frudan oral antikoag\u00fclan (apiksaban, rivaroksaban, dabigatran, edoksaban) kullanan hastalarda labil INR s\u00f6z konusu olamaz ve L bile\u015feni 0 puan al\u0131n\u0131r.<\/li>\n<li><strong>Zamanla yeniden de\u011ferlendirin.<\/strong> Kanama riski dinamiktir \u2014 ila\u00e7 de\u011fi\u015fiklikleri, yeni e\u015flik eden hastal\u0131klar veya ya\u015flanma skoru y\u00fckseltebilir; bu nedenle de\u011ferlendirmeyi kontrol vizitlerinde tekrarlay\u0131n.<\/li>\n<li><strong>4'in \u00fczerindeki skorlar nadirdir.<\/strong> \u00c7ok y\u00fcksek skorlar i\u00e7in yay\u0131mlanan kanama oranlar\u0131 az say\u0131da hastaya dayand\u0131\u011f\u0131ndan, 5 ve \u00fczeri skorlar i\u00e7in verilen tahmini yakla\u015f\u0131k kabul edin.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Atriyal fibrilasyonlu hastada antikoag\u00fclasyona ba\u015flamadan \u00f6nce bir y\u0131ll\u0131k maj\u00f6r kanama riskini tahmin edin. Uygun risk fakt\u00f6rlerini i\u015faretleyin; HAS-BLED skoru, kanama oran\u0131 ve yorum an\u0131nda ekranda g\u00f6r\u00fcn\u00fcr.<\/p>\n","protected":false},"author":3168,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[11],"tags":[26],"class_list":["post-3905","post","type-post","status-publish","format-standard","hentry","category-tisbi","tag-kardiyoloji"],"acf":[],"_links":{"self":[{"href":"https:\/\/wpcalc.com\/tr\/wp-json\/wp\/v2\/posts\/3905","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wpcalc.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wpcalc.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wpcalc.com\/tr\/wp-json\/wp\/v2\/users\/3168"}],"replies":[{"embeddable":true,"href":"https:\/\/wpcalc.com\/tr\/wp-json\/wp\/v2\/comments?post=3905"}],"version-history":[{"count":0,"href":"https:\/\/wpcalc.com\/tr\/wp-json\/wp\/v2\/posts\/3905\/revisions"}],"wp:attachment":[{"href":"https:\/\/wpcalc.com\/tr\/wp-json\/wp\/v2\/media?parent=3905"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wpcalc.com\/tr\/wp-json\/wp\/v2\/categories?post=3905"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wpcalc.com\/tr\/wp-json\/wp\/v2\/tags?post=3905"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}